๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Insulin growth factor-1 decreases muscle atrophy following denervation

โœ Scribed by Charles S. Day; Boonsin Buranapanitkit; Felix A. Riano; Matthew M. Tomaino; George Somogyi; Dean G. Sotereanos; Ryosuke Kuroda; Johnny Huard


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
633 KB
Volume
22
Category
Article
ISSN
0738-1085

No coin nor oath required. For personal study only.

โœฆ Synopsis


Despite modern microsurgical techniques for nerve repair, functional outcome following proximal injury is often unsatisfactory because irreversible muscle atrophy may develop before reinnervation occurs. Because insulin growth factor-1 (IGF-1) has been shown to improve muscle regeneration after injury, and may have a role in muscle preservation following denervation, the purpose of this investigation was to evaluate the histological, immunohistochemical, and electrophysiological differences between normal, denervated, and IGF-1-injected denervated muscle over an 8-week period. Denervated mice gastrocnemius muscles demonstrated a decrease in muscle weight, a decrease in myofiber diameter, an absence of muscle regeneration, an early increase in the number of neuromuscular junctions (NMJs), and a decrease in fast-twitch and maximum tetanic strength as compared to normal muscle up to 8 weeks following denervation. IGF-1-injected denervated muscle, on the other hand, sustained muscle diameter and muscle weight, maintained a smaller number of NMJs, and relatively sustained fast-twitch and maximum tetanic strength as compared to normal muscle over 8 weeks. These data suggest that IGF-1 may help prevent muscle atrophy and secondary functional compromise after denervation.


๐Ÿ“œ SIMILAR VOLUMES


Systemic administration of insulin-like
โœ Letizia Vergani; Anna Maria Di Giulio; Matteo Losa; Giuseppe Rossoni; Eugenio E. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 119 KB

Neonatal sciatic nerve axotomy causes motoneuron death and muscle denervation atrophy. The aim of the present study was to determine whether insulin-like growth factor-I (IGF-I) administration promotes muscle reinnervation and counteracts motor neuron loss after such an injury. Six weeks after sciat